acridine orange has been researched along with Osteogenic Sarcoma in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Fukuyama, Y; Kanai, E; Kawarai, S; Kayanuma, H; Maruo, T; Nemoto, Y; Nishiyama, Y; Orito, K | 1 |
Calvaruso, G; De Blasio, A; Di Fiore, R; Giuliano, M; Notaro, A; Pellerito, O; Sabella, S; Vento, R | 1 |
Liu, K; Liu, PC; Liu, R; Wu, X | 1 |
Avnet, S; Baldini, N; Fotia, C; Kusuzaki, K; Roncuzzi, L | 1 |
Akeda, K; Asanuma, K; Iino, T; Kusuzaki, K; Matsubara, T; Matsumine, A; Nakamura, T; Satonaka, H; Sudo, A; Tsujii, M; Uemura, T | 1 |
Holinka, J; Krepler, P; Marian, B; Pilz, M; Vavken, P | 1 |
Kusuzaki, K; Matsubara, T; Matsumine, A; Satonaka, H; Shintani, K; Uchida, A; Wakabayashi, T | 1 |
Ayala, AG; el-Naggar, AK; Hurr, K; Murray, J; Raymond, KA; Teague, K; Tu, ZN | 1 |
Ashihara, T; Hashiguchi, S; Hirasawa, Y; Kusuzaki, K; Minami, G; Murata, H; Nozaki, T; Takeshita, H | 1 |
Aomori, K; Ashihara, T; Hashiguchi, S; Hirasawa, Y; Kusuzaki, K; Minami, G; Murata, H; Suginoshita, T; Takeshita, H | 1 |
Ashihara, T; Hashiba, M; Hashiguchi, S; Hirasawa, Y; Kusuzaki, K; Murata, H; Nishimura, T; Takeshita, H | 1 |
Grant, LH; Pinto, A; Sarnat, HB; Trevenen, CL; Vogler, C | 1 |
12 other study(ies) available for acridine orange and Osteogenic Sarcoma
Article | Year |
---|---|
Recurrence analysis of intraoperative acridine orange-photodynamic therapy for dogs with intranasal tumors.
Topics: Acridine Orange; Animals; Dog Diseases; Dogs; Neoplasm Recurrence, Local; Osteosarcoma; Photochemotherapy; Treatment Outcome | 2021 |
Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis.
Topics: Acridine Orange; Apoptosis; Apoptosis Regulatory Proteins; Benzoxazines; Cadaverine; Cannabinoid Receptor Agonists; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Heat-Shock Proteins; Humans; Microtubule-Associated Proteins; Morpholines; Naphthalenes; Osteosarcoma; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand | 2014 |
Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry.
Topics: Acridine Orange; Apoptosis; Carrageenan; Cell Proliferation; Ethidium; Flow Cytometry; Humans; Organoselenium Compounds; Osteosarcoma; Propidium; Staining and Labeling | 2015 |
Acridine Orange is an Effective Anti-Cancer Drug that Affects Mitochondrial Function in Osteosarcoma Cells.
Topics: Acridine Orange; Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Humans; Lysosomes; Mitochondria; Osteosarcoma | 2015 |
Acridine orange inhibits pulmonary metastasis of mouse osteosarcoma.
Topics: Acridine Orange; Animals; Cell Line, Tumor; Fluorescent Dyes; Humans; In Vitro Techniques; Lung Neoplasms; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Osteosarcoma; Photochemistry; Prognosis; Treatment Outcome | 2011 |
Taurine chloramine induces apoptosis in human osteosarcoma cell lines.
Topics: Acridine Orange; Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Separation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Hypochlorous Acid; Microscopy, Fluorescence; Osteosarcoma; Taurine; Time Factors | 2012 |
Extracorporeal photodynamic image detection of mouse osteosarcoma in soft tissues utilizing fluorovisualization effect of acridine orange.
Topics: Acridine Orange; Animals; Cell Line, Tumor; Feasibility Studies; Fluorescence; Fluorescent Dyes; Mice; Osteosarcoma; Soft Tissue Neoplasms; Time Factors | 2006 |
DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
Topics: Acridine Orange; Adolescent; Adult; Aged; Aged, 80 and over; Aneuploidy; Bone Neoplasms; Cell Division; Child; Child, Preschool; Diagnosis, Differential; DNA, Neoplasm; Female; Flow Cytometry; Humans; Male; Middle Aged; Osteosarcoma; Prognosis; RNA, Neoplasm; Survival Analysis | 1995 |
Photodynamic inactivation with acridine orange on a multidrug-resistant mouse osteosarcoma cell line.
Topics: Acridine Orange; Animals; Bone Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Male; Mice; Mice, Inbred C3H; Osteosarcoma; Photochemotherapy; Ploidies; Tumor Cells, Cultured | 2000 |
Total tumor cell elimination with minimum damage to normal tissues in musculoskeletal sarcomas following photodynamic therapy with acridine orange.
Topics: Acridine Orange; Animals; Antineoplastic Agents; Bone Neoplasms; Curettage; Disease Models, Animal; Male; Mice; Mice, Inbred C3H; Musculoskeletal Diseases; Mutagens; Osteosarcoma; Photochemotherapy; Treatment Outcome | 2000 |
Acridine orange excited by low-dose radiation has a strong cytocidal effect on mouse osteosarcoma.
Topics: Acridine Orange; Animals; Cell Size; Cell Survival; Dose-Response Relationship, Radiation; Lung Neoplasms; Mice; Microscopy, Fluorescence; Neoplasm Transplantation; Osteosarcoma; Photochemotherapy; Survival Rate; Time Factors; Tumor Cells, Cultured; X-Rays | 2002 |
Acridine orange--RNA histofluorescence of sarcomas and small round cell tumors of childhood.
Topics: Acridine Orange; Adolescent; Child; Child, Preschool; Cytoplasm; Female; Humans; Male; Microscopy, Electron; Microscopy, Fluorescence; Osteosarcoma; Rhabdomyosarcoma; RNA, Neoplasm; Sarcoma; Sarcoma, Ewing; Staining and Labeling | 1990 |